ANTHONY ORLANDO: Open Payments
NPI 1457460743 · WOODBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,663 in 83 payments from 18 companies in 2025. Trend: 2023 $689 · 2024 $1,959 · 2025 $1,663
Food & beverage: $1,663
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $301 |
| Axsome Therapeutics, Inc. | 7 | $297 |
| Lilly USA, LLC | 12 | $190 |
| Novo Nordisk Inc | 11 | $172 |
| Vanda Pharmaceuticals Inc. | 9 | $167 |
| ABBVIE INC. | 10 | $154 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| Abbott Laboratories | 3 | $58 |
| Exact Sciences Corporation | 3 | $57 |
| PFIZER INC. | 2 | $41 |
Products named: Auvelity, FANAPT, AIRSUPRA, FARXIGA, VRAYLAR, Wegovy, MOUNJARO, JARDIANCE.
Industry payments across NJ — which companies pay providers there.
